Voydeya kit is a prescription medicine containing Danicopan, marketed by Alexion Pharmaceuticals, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store and dispense in the original container at 20°C to 25°C (68°F to 77°F)…
Key facts
- Active ingredient (INN)
- Danicopan
- Brand
- Voydeya
- Dosage form
- Kit
- Packs
- 1 kit
- Marketing authorisation holder
- Alexion Pharmaceuticals
- Manufacturer
- Alexion Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store and dispense in the original container at 20°C to 25°C (68°F to 77°F) with excursions permitted between 15°C and 30°C (59°F and 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- L04AJ09 Danicopan
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 29 March 2024
- Identifiers
- RxCUI 2678957, 2678963, 2678965 +5DailyMed set ID ab8d1cbd-a28b-4d49-82ab-5c7460719ac7NDC 25682-046Application NDA218037
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 kit in 1 carton * 90 tablet, film coated in 1 bottle * 90 tablet, film coated in 1 bottle | 25682-046-92 | Alexion Pharmaceuticals | 29 March 2024 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Danicopan
Clinical summary
Danicopan is a complement factor D inhibitor indicated as add-on therapy to ravulizumab or eculizumab for the treatment of extravascular hemolysis (EVH) in adults with paroxysmal nocturnal hemoglobinuria (PNH). MedsAcross supplies Danicopan for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about DanicopanFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Voydeya prescribing information (Alexion Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
- Voydeya: European public assessment report (EPAR) · European Medicines Agency
Need Voydeya kit for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.